Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05458895 · ClinicalTrials.gov registry record · NA
Evaluating E-Cigarette Nicotine Form, Concentration, and Flavors Among Youth
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT05458895: Completed NA study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT05458895 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05458895, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
This clinical trial examines the influence of nicotine form, concentration, and e-liquid flavor on youth vaping behavior, as well as the heart and lung effects associated with this behavior. Electronic cigarette (e-cig) "vaping", while being promoted as a safer alternative to conventional cigarettes, has disproportionately attracted adolescents and young adults ("youth"). This trial may help researchers understand how nicotine form, concentration, and flavor affects people's vaping behaviors and health.
Primary Outcome
Plasma nicotine concentration from blood drawn (3mL) 4 times in each session at baseline (0 min), 5 min., 10 min., 35 min.
Interventions
- OTHER ECIG lab session 1
- OTHER ECIG lab session 2
- OTHER ECIG lab session 3
- OTHER ECIG lab session 4
- OTHER ECIG lab session 5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2021-12-02 |
| Est. Completion | 2023-08-07 |
| Phase | NA |
What the finished NCT05458895 record still lists
NCT05458895 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 5 interventions - of which ECIG lab session 1 is the first listed.
NCT05458895 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05458895 about?
NCT05458895 is a clinical study titled "Evaluating E-Cigarette Nicotine Form, Concentration, and Flavors Among Youth". This clinical trial examines the influence of nicotine form, concentration, and e-liquid flavor on youth vaping behavior, as well as the heart and lung effects associated with this behavior. Electronic cigarette (e-cig) "vaping", while being promoted as a safer alternative to conventional cigarettes...
What is the current status of trial NCT05458895?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2021-12-02. Estimated completion is 2023-08-07.
What interventions are being tested in trial NCT05458895?
The interventions under investigation include: ECIG lab session 1 (OTHER), ECIG lab session 2 (OTHER), ECIG lab session 3 (OTHER), ECIG lab session 4 (OTHER), ECIG lab session 5 (OTHER).
Who is sponsoring clinical trial NCT05458895?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05458895's enrollment target sits among peer trials
88 972nd of 2000 higher than 1,027 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI